Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cytomegalovirus Infection

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    December 2021
  1. SAULLO JL, Baker AW, Snyder LD, Reynolds JM, et al
    Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis.
    J Heart Lung Transplant. 2021 Dec 22. pii: S1053-2498(21)02626.
    PubMed     Abstract available


  2. GAO Q, Hartwig MG, Todd JL
    Bridging the translation gap in cytomegalovirus therapeutics through ex vivo lung perfusion: Opportunities and challenges.
    J Heart Lung Transplant. 2021 Dec 5. pii: S1053-2498(21)02615.
    PubMed    


    October 2021
  3. RIBEIRO RVP, Ku T, Wang A, Pires L, et al
    Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin.
    J Heart Lung Transplant. 2021 Oct 25. pii: S1053-2498(21)02544.
    PubMed     Abstract available


    June 2021
  4. ORESCHAK K, Saba LM, Rafaels N, Ambardekar AV, et al
    Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.
    J Heart Lung Transplant. 2021 Jun 12. pii: S1053-2498(21)02342.
    PubMed     Abstract available


    May 2021
  5. VIETZEN H, Hartenberger S, Jaksch P, Puchhammer-Stockl E, et al
    Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
    J Heart Lung Transplant. 2021 May 31. pii: S1053-2498(21)02324.
    PubMed     Abstract available


    November 2020
  6. KANWAR MK, Khush KK, Pinney S, Sherman C, et al
    Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
    J Heart Lung Transplant. 2020 Nov 22. pii: S1053-2498(20)31840.
    PubMed     Abstract available


    August 2020
  7. STANKOVIC S, Davey MS, Shaw EM, von Borstel A, et al
    Cytomegalovirus replication is associated with enrichment of distinct gammadelta T cell subsets following lung transplantation: A novel therapeutic approach?
    J Heart Lung Transplant. 2020 Aug 26. pii: S1053-2498(20)31703.
    PubMed     Abstract available


    April 2020
  8. VP RIBEIRO R, Ku T, Ferreira VH, Galasso M, et al
    Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  9. KANWAR M, Pinney S, Shah P, Kobashigawa J, et al
    Correlation of Longitudinal Gene-Expression Profiling (GEP) Score to Cytomegalovirus (CMV) Infection: Results from the Outcomes Allomap(R) Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  10. STANKOVIC S, Davey MS, Shaw EM, Cristiano Y, et al
    A Potential Role for NKG2C+ gammadelta T Cells as a Cellular Therapy in Combating Post-Lung Transplant Cytomegalovirus Infection.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  11. PIERCE BJ, Pham C, Balk SV, Huang H, et al
    Cytomegalovirus Immune Globulin (CMV-Ig): An Old Drug with Fewer Tricks - Removal of Prophylactic CMV-Ig Administration in CMV Mismatched Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  12. GIFT T, Palafox J, Jones K, Imburgia T, et al
    CMV Viremia after Discontinuation of Valganciclovir Prophylaxis in Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  13. MOSS I, Brueckner A, Rumore A
    Comparison of Outcomes in Heart Transplant Recipients Receiving CMV Prophylaxis with CMV IVIG with Valganciclovir versus Valganciclovir Alone.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  14. COUTANCE G, Boutolleau D, Rouvier P, Leprince P, et al
    Cytomegalovirus Infections are Frequent after Heart Transplantation but Do Not Increase the Risk of Biopsy-Proven Allograft Rejection in the Modern Era.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  15. PUING A, Couture-Cosette A, Quintero O, Multani A, et al
    6-month vs 12-month CMV Prophylaxis for CMV-Mismatched Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  16. CALLAN PD, Yonan N, Santhanakrishnan K, Shaw SM, et al
    Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


    January 2020
  17. POGLAJEN G, Zemljic G, Frljak S, Cerar A, et al
    QuantiFERON-CMV guided virostatic prophylaxis after heart transplantation.
    J Heart Lung Transplant. 2020 Jan 21. pii: S1053-2498(20)30010.
    PubMed    


    September 2019
  18. HELIOVAARA E, Husain S, Martinu T, Singer LG, et al
    Drug-resistant cytomegalovirus infection after lung transplantation: Incidence, characteristics, and clinical outcomes.
    J Heart Lung Transplant. 2019 Sep 10. pii: S1053-2498(19)31672.
    PubMed     Abstract available


    January 2019
  19. MOAYEDI Y, Gomez CA, Fan CPS, Miller RJH, et al
    Infectious complications after heart transplantation in patients screened with gene expression profiling.
    J Heart Lung Transplant. 2019 Jan 7. pii: S1053-2498(19)30006.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: